Innate Pharma S.A. (IPHA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innate Pharma S.A.

    NASDAQ: IPHA · Real-Time Price · USD
    2.02
    0.01 (0.50%)
    At close: Oct 03, 2025, 3:58 PM
    2.03
    0.50%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    Innate Pharma S.A. Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 5.14M 12.62M 28.9M 51.9M 43.65M 49.58M 44.06M 12.11M 36.31M
    Cost of Revenue
    		 -8.56M n/a 53.65M 40.3M 29.08M 25.83M 25.38M 23.5M 15.26M
    Gross Profit
    		 13.69M 12.62M -19.86M 16.49M 14.57M 23.75M 18.69M -11.39M 21.05M
    Operating Income
    		 -50.69M -51.58M -33.73M -12.67M -34.06M -24.63M -26.73M -57.48M -43.99M
    Interest Income
    		 101K 2.64M 14.48M 12.9M 1.31M 350K 4K 7.5K 32K
    Pretax Income
    		 -46.05M -49.47M -29.2M -7.57M -71.25M -66.01M -27.31M -58.07M -89.19M
    Net Income
    		 -46.05M -49.47M -34.05M -7.57M -62.69M -58.1M -22.79M -52.81M -77.37M
    Selling & General & Admin
    		 12.12M 11.93M 18.73M 17.69M 18.11M 20.94M 16.88M 18.89M 29.44M
    Research & Development
    		 43.42M 51.98M 53.65M 52.98M 53.57M 48.84M 49.49M 46.13M 42.11M
    Other Expenses
    		 8.84M 283K -53.64M -24.57M n/a n/a n/a n/a n/a
    Operating Expenses
    		 64.38M 64.2M 18.73M 46.1M 71.68M 69.78M 66.37M 65.02M 71.55M
    Interest Expense
    		 34K 634K 3.62M 3.35M 418K 94K n/a n/a n/a
    Selling & Marketing Expenses
    		 -8K n/a 338K 245K 148.5K 265K 326.5K 196.5K 222K
    Cost & Expenses
    		 55.83M 64.2M 62.63M 64.57M 77.71M 74.21M 70.79M 69.59M 80.3M
    Income Tax Expense
    		 n/a n/a n/a -4.85M -8.62M -8.04M -11.93M -12.59M -11.82M
    Shares Outstanding (Basic)
    		 85.38M 81.05M 79.88M 80.59M 80.32M 80.19M 79.74M 79.54M 79M
    Shares Outstanding (Diluted)
    		 86.94M 81.05M 80.87M 80.59M 83.78M 80.19M 81.87M 79.54M 79M
    EPS (Basic)
    		 -0.55 -0.61 -0.43 -0.1 -0.78 -0.72 -0.29 -0.67 -0.98
    EPS (Diluted)
    		 -0.55 -0.61 -0.43 -0.1 -0.78 -0.72 -0.29 -0.67 -0.98
    EBITDA
    		 -46.41M -46.91M -35.96M -9.56M -64.81M -59.42M -20.69M -51.29M -78.19M
    EBIT
    		 -48.02M -48.91M -38.58M -15.08M -15.27M -8.21M -25.04M -57.76M -88.84M
    Depreciation & Amortization
    		 1.61M 1.99M 2.62M 5.52M 6.03M 4.42M 4.42M 4.57M 8.76M

    Add to Watchlist